Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717442 · ClinicalTrials.gov registry record · Phase 3
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
A Phase 3 study, sponsored by Otonomy.
- Terminated
- Registry status
- Phase 3
- Development phase
- 176
- Enrollment target
NCT02717442: Clinical Trial Phase 3 study, sponsored by Otonomy.
NCT02717442 is a Phase 3 study that was terminated before completion, run by Otonomy. The registered enrollment target is 176 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02717442, a Phase 3 study, was terminated before completion, sponsored by Otonomy.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 176 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Primary Outcome
In the Full Analysis Set (FAS)-1 population, the number of DVDs at Week 12 (the 4-week \[28 days\] interval from Week 9 through Week 12) was compared between OTO-104 and placebo. Week 12 = 12 weeks after dosing at the Baseline visit. The Baseline visit occurred at the end of lead-in. No intervention was administered during lead-in.
Interventions
- DRUG Placebo
- DRUG OTO-104
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2016-03-21 |
| Est. Completion | 2017-09-15 |
| Phase | Phase 3 |
Why NCT02717442 stopped before completion
NCT02717442 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02717442 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02717442 about?
NCT02717442 is a clinical study titled "Study of OTO-104 in Subjects With Unilateral Meniere's Disease". The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
What is the current status of trial NCT02717442?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 176 participants. The study started on 2016-03-21. Estimated completion is 2017-09-15.
What interventions are being tested in trial NCT02717442?
The interventions under investigation include: Placebo (DRUG), OTO-104 (DRUG).
Who is sponsoring clinical trial NCT02717442?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02717442's enrollment target sits among peer trials
176 1438th of 2000 higher than 561 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI